Lawmakers Press FDA To Get Tough On Drug Trial Reporting

Law360, New York (February 14, 2012, 7:27 PM EST) -- Three Democratic lawmakers on Tuesday pressed the U.S. Food and Drug Administration to better enforce laws requiring the public reporting of clinical drug trial results, after a study found that such results had been seriously under-reported.

Results were only reported in 22 percent of clinical drug trials where such reporting was mandatory, according to a study published in January in the British Medical Journal, which looked at trials performed in 2009. Under the law, results from applicable trials must be reported via within a year....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.